title: CTLA-4 polymorphisms are not associated with ocular inflammatory disease.
abstract: Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) is regarded with other molecules such as HLA, PTPN22 and CARD15 as genetic master switches of autoimmunity. Single nucleotide polymorphisms (SNPs) in the genes encoding these molecules have been associated with autoimmune conditions. We analysed the SNPs -318C/T and 49A/G in CTLA-4 in patients with Behcet's disease (BD), patients with intermediate uveitis and appropriate controls. Blood was collected from 236 patients with BD from the UK and the Middle East (ME), all fulfilling the International Study Group criteria for the diagnosis of BD, and 143 patients with idiopathic intermediate uveitis were recruited from the Medical Eye Unit at St Thomas' Hospital. Samples from healthy individuals from each geographical centre were used as controls. DNA was prepared by standard methods, and SNPs -318 and 49 in CTLA-4 were detected by a polymerase chain reaction-sequence specific primers (PCR-SSP) assay using primer mixes. The results showed that there was no association with either polymorphism in patients with BD from the UK or the ME. Similarly, there was no association in patients with intermediate uveitis. Moreover, there was no association with SNP in CTLA-4 and disease manifestations in BD or outcome in patients with intermediate uveitis. Both BD and intermediate uveitis have HLA associations, but there is no difference in distribution of CTLA-4 polymorphisms that are associated with other autoimmune diseases. The lack of association with polymorphisms in CTLA-4 and other master controlling genes of autoimmunity suggests that mechanisms that mediate such a description for BD and intermediate uveitis have still to be elucidated.
authors.affiliation: Department of Ophthalmology, King's College London, London, UK.
authors.forename: L
authors.initials: L
authors.lastname: Bye
authors.forename: N
authors.initials: N
authors.lastname: Modi
authors.forename: M R
authors.initials: MR
authors.lastname: Stanford
authors.forename: E
authors.initials: E
authors.lastname: Kondeatis
authors.forename: R
authors.initials: R
authors.lastname: Vaughan
authors.forename: F
authors.initials: F
authors.lastname: Fortune
authors.forename: C
authors.initials: C
authors.lastname: Kanawati
authors.forename: E
authors.initials: E
authors.lastname: Ben-Chetrit
authors.forename: M
authors.initials: M
authors.lastname: Ghabra
authors.forename: P I
authors.initials: PI
authors.lastname: Murray
authors.forename: G R
authors.initials: GR
authors.lastname: Wallace
mesh_terms: D015703:Antigens, CD / Q000235:genetics*; D001528:Behcet Syndrome / Q000235:genetics* / Q000473:pathology; D060908:CTLA-4 Antigen; D016022:Case-Control Studies; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011446:Prospective Studies; D015867:Uveitis, Intermediate / Q000235:genetics*
chemical_list: D015703:Antigens, CD; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human